These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 30314728)

  • 1. Chemokine levels predict progressive liver disease in Down syndrome patients with transient abnormal myelopoiesis.
    Kinjo T; Inoue H; Kusuda T; Fujiyoshi J; Ochiai M; Takahata Y; Honjo S; Koga Y; Hara T; Ohga S
    Pediatr Neonatol; 2019 Aug; 60(4):382-388. PubMed ID: 30314728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma TGF-β1 Levels Are Elevated in Down Syndrome Infants with Transient Abnormal Myelopoiesis.
    Maeda H; Go H; Imamura T; Sato M; Momoi N; Hosoya M
    Tohoku J Exp Med; 2016 Sep; 240(1):1-5. PubMed ID: 27546516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent advances in the understanding of transient abnormal myelopoiesis in Down syndrome.
    Watanabe K
    Pediatr Int; 2019 Mar; 61(3):222-229. PubMed ID: 30593694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine Profiles in Pericardial Effusion in a Down Syndrome Infant with Transient Abnormal Myelopoiesis.
    Shitara Y; Takahashi N; Aoki Y; Kato M; Nishimura R; Tsuchida S; Oka A
    Tohoku J Exp Med; 2017 Feb; 241(2):149-153. PubMed ID: 28202857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical features of 35 Down syndrome patients with transient abnormal myelopoiesis at a single institution.
    Yamato G; Park MJ; Sotomatsu M; Kaburagi T; Maruyama K; Kobayashi T; Nishi A; Sameshima K; Ohki K; Hayashi Y
    Int J Hematol; 2021 May; 113(5):662-667. PubMed ID: 33394336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis.
    Kuan WP; Tam LS; Wong CK; Ko FW; Li T; Zhu T; Li EK
    J Rheumatol; 2010 Feb; 37(2):257-64. PubMed ID: 20032101
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL2, CXCL8, CXCL9 and CXCL10 serum levels increase with age but are not altered by treatment with hydroxychloroquine in patients with osteoarthritis of the knees.
    Bonfante HL; Almeida CS; Abramo C; Grunewald STF; Levy RA; Teixeira HC
    Int J Rheum Dis; 2017 Dec; 20(12):1958-1964. PubMed ID: 25955863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete blood count differences in a cohort of Down syndrome neonates with transient abnormal myelopoiesis screened for GATA1 pathogenic variants.
    Orozco-Vela M; Corona-Rivera A; Cruz-Osorio RM; Mendoza-Maldonado L; Márquez-Mora A; Barba-Barba CC; Peña-Padilla C; Baldomero-López A; Bobadilla-Morales L; Corona-Rivera JR
    Am J Med Genet A; 2020 Sep; 182(9):2085-2093. PubMed ID: 32681702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biology and management of transient abnormal myelopoiesis (TAM) in children with Down syndrome.
    Roy A; Roberts I; Vyas P
    Semin Fetal Neonatal Med; 2012 Aug; 17(4):196-201. PubMed ID: 22421527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pro-inflammatory cytokinemia is frequently found in Down syndrome patients with hematological disorders.
    Shimada A; Hayashi Y; Ogasawara M; Park MJ; Katoh M; Minakami H; Kitoh T; Kojima S; Kawa K; Kimura H
    Leuk Res; 2007 Sep; 31(9):1199-203. PubMed ID: 17055049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine profiling in 128 patients with transient abnormal myelopoiesis: a report from the JPLSG TAM-10 trial.
    Yamato G; Tsumura Y; Muramatsu H; Shimada A; Imaizumi T; Tsukagoshi H; Kaburagi T; Shiba N; Yamada Y; Deguchi T; Kawai T; Terui K; Ito E; Watanabe K; Hayashi Y
    Blood Adv; 2024 Jun; 8(12):3120-3129. PubMed ID: 38691583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of liver disease in transient abnormal myelopoiesis with fish oil emulsion.
    Watanabe T; Amari S; Tsukamoto K; Ito Y; Tomizawa D; Yoshioka T; Kanamori Y
    Pediatr Int; 2017 Apr; 59(4):515-518. PubMed ID: 28401746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Investigate circulating levels of chemokines and evaluate the correlation between these chemokines and liver function indicators in autoimmune hepatitis].
    Li YL; Liu N; Zhao DT; Li ZM; Zhang HP; Liu YM; Yan HP; Zhao Y
    Zhonghua Gan Zang Bing Za Zhi; 2013 Apr; 21(4):299-303. PubMed ID: 24021794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PRAME immunohistochemical staining in transient abnormal myelopoiesis and myeloid leukemia associated with Down syndrome.
    Chisholm KM; Rivetta CV; Heerema-McKenney A
    Ann Clin Lab Sci; 2015; 45(2):121-7. PubMed ID: 25887863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematological disorders in children with Down syndrome.
    Triarico S; Trombatore G; Capozza MA; Romano A; Mastrangelo S; Attinà G; Maurizi P; Ruggiero A
    Expert Rev Hematol; 2022 Feb; 15(2):127-135. PubMed ID: 35184659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient Abnormal Myelopoiesis and AML in Down Syndrome: an Update.
    Bhatnagar N; Nizery L; Tunstall O; Vyas P; Roberts I
    Curr Hematol Malig Rep; 2016 Oct; 11(5):333-41. PubMed ID: 27510823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct GATA1 Point Mutations in Monozygotic Twins With Down Syndrome and Transient Abnormal Myelopoiesis From a Triplet Pregnancy: A Case Report and Review of Literature.
    Yin L; Lovell MA; Wilson ML; Wei Q; Liang X
    Am J Clin Pathol; 2016 Dec; 146(6):753-759. PubMed ID: 28028114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [THE ROLE OF CYTOKINES AND CHEMOKINES IN LABORATORY DIAGNOSTIC OF CHRONIC VIRAL HEPATITIS C].
    Semenov AV; Arsentieva NA; Lubimova NE; Tulienev SV; Basina VV; Esaulenko EV; Totolyan AA
    Klin Lab Diagn; 2015 Aug; 60(8):45-51. PubMed ID: 26596048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481.
    Massey GV; Zipursky A; Chang MN; Doyle JJ; Nasim S; Taub JW; Ravindranath Y; Dahl G; Weinstein HJ;
    Blood; 2006 Jun; 107(12):4606-13. PubMed ID: 16469874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monocyte Chemoattractant Protein-1 (MCP-1) as a Potential Therapeutic Target and a Noninvasive Biomarker of Liver Fibrosis Associated With Transient Myeloproliferative Disorder in Down Syndrome.
    Kobayashi K; Yoshioka T; Miyauchi J; Nakazawa A; Yamazaki S; Ono H; Tatsuno M; Iijima K; Takahashi C; Okada Y; Teranishi K; Matsunaga T; Matsushima C; Inagaki M; Suehiro M; Suehiro S; Nishitani M; Kubota H; Iio J; Nishida Y; Katayama T; Takada N; Watanabe K; Yamamoto T; Yasumizu R; Matsuoka K; Ohki K; Kiyokawa N; Maihara T; Usami I
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e285-e289. PubMed ID: 28267084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.